Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Luis Paulo Ugarte Pelaez, Yadith Karina Lopez-Garcia, Antonio Vega Mateos, Perla R. Colunga-Pedraza, Luz Tarin-Arzaga, Andres Gomez-De Leon, Olga Cantu, Jose Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 2364.

https://doi.org/10.1182/blood-2024-208836

Published: 2024

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino

Blood (2024) 144 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2024-210332

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Low-Dose Venetoclax with Azacitidine in Adults with Acute Myeloid Leukemia: Impact of Phenotype on Outcomes

Luis Ugarte, Yadith Karina Lopez-Garcia, Fernando De La Garza, Francisco Rubio, Michelle Morcos, Alexia Gonzalez, Ana Cristina Tejada Vasquez, Antonio Vega Mateos, Gerardo Garcia-Salas, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 5964.

https://doi.org/10.1182/blood-2024-212023

Published: 2024

Journal Articles

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 6474.

https://doi.org/10.1182/blood-2024-209615

Published: 2024

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Andres Noyola-Perez, Alejandra J. Osuna-Corrales, Manali I. Patel, Jorge Cortes, Lillian Sung, Juan C. Angulo-Lozano, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 494.

https://doi.org/10.1182/blood-2023-189576

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Paola Spirko, Juan Alejandro Ospina-Idárraga, Jaime Valdes Cespedes, Karen Pellon, Laura Korin, Perla R. Colunga-Pedraza, Henry Idrobo, Andrea Noboa, Luis Mario Villela, Arianna Robles, Alana Von Glasenapp, Perla N Britos, Yusaima Rodriguez, Rosa Oliday Rios Jiménez, Camila Peña, Luis Felipe Rubalcava, Jorge J. Castillo

Blood (2023) 142 (Supplement 1): 6326.

https://doi.org/10.1182/blood-2023-190960

Published: 2023

Journal Articles

Extramedullary Relapse after Chemotherapy-Only Conditioning in Latin-Americans with Acute Leukemia: A Common Problem

Christianne Bourlon De Los Rios, MDMSc, Aldo A. Acosta-Medina, MD, Luis Arias-Espinosa, MD, Perla R Colunga Pedraza, MD, Jose Angel Hawing-Zarate, MD, José Miguel Alvarez Blanco, MD, Guillermo Pacheco-Gutierrez, MD, Georgina Barrera-Lumbreras, BSc, Andres Gomez-De Leon, MD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-137633

Published: 2020

Journal Articles

The Leukoreductive Power of Vinblastine in Acute Myeloid Leukemia with Hyperleukocytosis: A Pilot Study

Fernando De La Garza, MD, Perla R. Colunga Pedraza, MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-143404

Published: 2020

Journal Articles

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Perla R. Colunga Pedraza, MD, Julia Esther Colunga Pedraza, MD, Andres Gomez-De Leon, MD, Mónica Bustillos Muñoz, MD, Karen Lorena Osorno-Rodriguez, MD, Jose Angel Hawing, MD, Oscar Gonzalez Llano, MD, Yajaira Valentine Jimenez-Antolinez, MD, Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-142035

Published: 2020

Journal Articles

Contributions to Global Hematology from Low and Middle-Income Countries: Insights from ASH 2018

Andrés Gómez-De León, MD, Perla R. Colunga Pedraza, MD, Luz del Carmen Tarín Arzaga, MD, Emmanuel Bugarin-Estrada, MD, David Gómez-De León, Lillian Sung, MD PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2123.

https://doi.org/10.1182/blood-2019-130053

Published: 2019

Journal Articles

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

Cesar Homero Gutierrez-Aguirre, PhD, Olga Graciela Cantu Rodriguez, MD, Fernando De la Garza-Salazar, MD, Rosario Salazar Riojas, Chem., Andres Gomez De Leon, MD, Perla R. Colunga Pedraza, MD, Geraldina Guerrero-González, PhD, Jose Carlos Jaime, MD PhD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD, Consuelo Mancias, MD

Blood (2019) 134 (Supplement_1): 1967.

https://doi.org/10.1182/blood-2019-131791

Published: 2019

Journal Articles

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Mónica Bustillos Muñoz, MD, Diana E Garcia-Camarillo, MD, Rosario Salazar Riojas, Chem., Leslie Silva López, Quem., Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2057.

https://doi.org/10.1182/blood-2019-131627

Published: 2019

Journal Articles

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Andrés Gómez-De León, MD, Dalila Marisol Alvarado Navarro, MD, Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, David Gomez-Almaguer, MD, Rosario Salazar Riojas, Chem., Olga Graciela Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Jose Carlos Jaime, MD PhD, Cesar Homero Gutierrez-Aguirre, PhD

Blood (2019) 134 (Supplement_1): 4476.

https://doi.org/10.1182/blood-2019-129516

Published: 2019

NARROW

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Low-Dose Venetoclax with Azacitidine in Adults with Acute Myeloid Leukemia: Impact of Phenotype on Outcomes

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Extramedullary Relapse after Chemotherapy-Only Conditioning in Latin-Americans with Acute Leukemia: A Common Problem

The Leukoreductive Power of Vinblastine in Acute Myeloid Leukemia with Hyperleukocytosis: A Pilot Study

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Contributions to Global Hematology from Low and Middle-Income Countries: Insights from ASH 2018

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only